LPCN   $5.0661  4.89% Market Closed

Lipocine Inc
Total Cash 22.55M
totalCashPerShare 4.216
EBITDA -9.67M
Total Debt 245.38K
quickRatio 12.398
currentRatio 12.56
Total Revenue 4.80M
debtToEquity 1.157
Revenue/Share 0.903
ROA -0.22673
ROE -0.34116
grossProfits
freeCashflow -4.61M
operatingCashflow -4.72M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins -2.01502
operatingMargins -36.76177
profitMargins -1.7680401
enterpriseValue 2.35M
forwardPE -4.9569893
floatShares 5.19M
sharesOutstanding 5.35M
sharesShort 134.37K
sharesShortPriorMonth 116.08K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.10%
Short Ratio help_outline 4.81%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 3.966
Price To Book help_outline 1.16
earningsQuarterlyGrowth
netIncomeToCommon -8.49M
trailingEps -1.62%
forwardEps -0.93%
enterpriseToEbitda -0.24
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 21
lastUpdated Sept. 16, 2024, 11:59 a.m.